Literature DB >> 28800184

Use of non-pharmacological strategies for pain relief in addiction treatment patients with chronic pain.

Lewei Allison Lin1,2, Amy S B Bohnert1,2, Mary Jannausch2, Jenna Goesling3, Mark A Ilgen1,2.   

Abstract

BACKGROUND AND OBJECTIVES: We examined use of non-pharmacological treatments for pain in addiction treatment patients.
METHODS: Patients in addiction treatment with chronic pain (N = 501) were classified based on use of non-pharmacological pain treatments. Demographic and clinical correlates were compared.
RESULTS: A total of 49% (N = 243) of patients used a non-pharmacological treatment in the past year versus 72% (N = 361) who used opioids. Non-pharmacological treatment users were more likely to use opioids and other pain medications.
CONCLUSIONS: Non-pharmacological treatments are less commonly used than opioids by addiction treatment patients. SCIENTIFIC SIGNIFICANCE: Findings highlight the need to better understand pain treatment decision-making among addiction treatment patients. (Am J Addict 2017;26:564-567).
© 2017 American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28800184      PMCID: PMC5576866          DOI: 10.1111/ajad.12600

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  10 in total

1.  Physical therapy for chronic low back pain in North Carolina: overuse, underuse, or misuse?

Authors:  Janet K Freburger; Timothy S Carey; George M Holmes
Journal:  Phys Ther       Date:  2011-02-17

Review 2.  Acceptance and related processes in adjustment to chronic pain.

Authors:  Miles Thompson; Lance M McCracken
Journal:  Curr Pain Headache Rep       Date:  2011-04

3.  Conventional and nonconventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: a needs assessment study.

Authors:  Declan T Barry; Mark Beitel; Christopher J Cutter; Dipa Joshi; Jean Falcioni; Richard S Schottenfeld
Journal:  J Addict Med       Date:  2010-06       Impact factor: 3.702

4.  Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.

Authors:  John T Farrar; James P Young; Linda LaMoreaux; John L Werth; Michael R Poole
Journal:  Pain       Date:  2001-11       Impact factor: 6.961

5.  A randomized trial of a pain management intervention for adults receiving substance use disorder treatment.

Authors:  Mark A Ilgen; Amy S B Bohnert; Stephen Chermack; Carly Conran; Mary Jannausch; Jodie Trafton; Frederic C Blow
Journal:  Addiction       Date:  2016-04-15       Impact factor: 6.526

6.  Associations among pain, non-medical prescription opioid use, and drug overdose history.

Authors:  Erin E Bonar; Mark A Ilgen; Maureen Walton; Amy S B Bohnert
Journal:  Am J Addict       Date:  2013-06-14

7.  The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription.

Authors:  Mark J Edlund; Bradley C Martin; Joan E Russo; Andrea DeVries; Jennifer B Braden; Mark D Sullivan
Journal:  Clin J Pain       Date:  2014-07       Impact factor: 3.442

8.  Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone.

Authors:  Declan T Barry; Jonathan D Savant; Mark Beitel; Christopher J Cutter; Brent A Moore; Richard S Schottenfeld; David A Fiellin
Journal:  J Addict Med       Date:  2012-12       Impact factor: 3.702

9.  Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST).

Authors:  Rachel Humeniuk; Robert Ali; Thomas F Babor; Michael Farrell; Maria L Formigoni; Jaroon Jittiwutikarn; Roseli B de Lacerda; Walter Ling; John Marsden; Maristela Monteiro; Sekai Nhiwatiwa; Hemraj Pal; Vladimir Poznyak; Sara Simon
Journal:  Addiction       Date:  2008-03-28       Impact factor: 6.526

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.